The Recipient with a Failing Graft

Hepatitis C in Renal Disease, Hemodialysis and Transplantation

This flow follows how HCV-related glomerular injury and chronic allograft damage threaten a transplanted kidney.

increasing

Bearing strength in each event

decreasing

Early Proteinuria Early Proteinuria from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Early Proteinuria The first sign Proteinuria and microscopic hematuria may be the earliest visible evidence of de novo HCV-associated renal disease.

Early Proteinuria from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Early Proteinuria The first sign Proteinuria and microscopic hematuria may be the earliest visible evidence of de novo HCV-associated renal disease.

Early Proteinuria The first sign Proteinuria and microscopic hematuria may be the earliest visible evidence of de novo HCV-associated renal disease. The patient can have few systemic symptoms while the graft is already under attack. Differential danger Transplant glomerulopathy, chronic allograft nephropathy, rejection, and HCV-related MPGN may overlap. Kidney biopsy is required to separate immune-complex injury from alloimmune damage.

Glomerular Lesion Glomerular Lesion from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Glomerular Lesion Two injuries meet HCV-related MPGN may show mesangial proliferation, double contours, and IgM or complement deposits.

Glomerular Lesion from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Glomerular Lesion Two injuries meet HCV-related MPGN may show mesangial proliferation, double contours, and IgM or complement deposits.

Glomerular Lesion Two injuries meet HCV-related MPGN may show mesangial proliferation, double contours, and IgM or complement deposits. Transplant glomerulopathy may coexist, making the graft a site of both viral and alloimmune injury. Accelerated loss The combined lesion can produce hypertension, nephrotic syndrome, and declining filtration. A complication once considered uncommon becomes a central explanation for graft failure.

Limited Rescue Limited Rescue from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Limited Rescue Supportive first steps Antiproteinuric treatment and careful immunosuppression adjustment may slow damage.

Limited Rescue from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Limited Rescue Supportive first steps Antiproteinuric treatment and careful immunosuppression adjustment may slow damage.

Limited Rescue Supportive first steps Antiproteinuric treatment and careful immunosuppression adjustment may slow damage. Interferon is generally avoided because it can provoke Acute rejection. Targeted options Rituximab therapy may suppress cryoglobulin-related disease, but infection and viral replication remain concerns. The graft’s fate depends on balancing immune control against overimmunosuppression.

after Kidney transplantation

when graft dysfunction progresses

during established allograft injury